Xellsmart Bio-pharmaceutical (suzhou) Co., Ltd.
Clinical trials sponsored by Xellsmart Bio-pharmaceutical (suzhou) Co., Ltd., explained in plain language.
-
Lab-Grown nerve cells injected into spinal cords in pioneering trial
Disease control Recruiting nowThis early-stage trial is testing whether injecting lab-grown nerve cells into the spinal cord is safe for people with a recent spinal cord injury. Researchers will enroll 12 participants who were injured 2 to 8 weeks ago to receive the experimental cell therapy. The main goal is…
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
Scientists test brain cell transplants to fight Parkinson's
Disease control Recruiting nowThis study is testing whether injecting lab-grown brain cells into patients can help control early-onset Parkinson's disease. Researchers will give 90 participants a single injection of these cells and monitor their safety and effect on symptoms for a year. The goal is to see if …
Phase: PHASE1, PHASE2 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
First human test of Lab-Grown motor neurons for ALS patients
Disease control Recruiting nowThis early-stage study is testing whether motor neuron cells grown from stem cells are safe for people with ALS. Researchers will give these lab-grown cells to 12 ALS patients and monitor them closely for side effects. The main goal is to see if this experimental treatment is wel…
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC
-
Doctors test brain cell transplants to fight Parkinson's
Disease control Recruiting nowThis is an early safety study testing a new treatment for Parkinson's disease. Doctors will inject lab-grown brain cells directly into the brains of 12 patients with moderate to advanced Parkinson's. The main goal is to see if this procedure is safe and tolerable, not to cure the…
Phase: PHASE1 • Sponsor: XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. • Aim: Disease control
Last updated Feb 17, 2026 14:38 UTC